Cargando…
The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor
PURPOSE: This study was designed to evaluate the efficacy of medical treatment of Peyronie's disease. MATERIALS AND METHODS: A total of 109 patients with Peyronie's disease who had been treated from January 2011 to December 2014 were retrospectively reviewed in this study. Forty-four patie...
Autores principales: | Park, Tae Yong, Jeong, Hyeong Guk, Park, Jong Jin, Chae, Ji Yun, Kim, Jong Wook, Oh, Mi Mi, Park, Hong Seok, Kim, Je Jong, Moon, Du Geon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Sexual Medicine and Andrology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853769/ https://www.ncbi.nlm.nih.gov/pubmed/27169128 http://dx.doi.org/10.5534/wjmh.2016.34.1.40 |
Ejemplares similares
-
AB081. Effects of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors in the Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016) -
AB093. The efficacy of medical treatment of Peyronie’s disease: Potaba monotherapy vs. combination therapy with Tamoxifen, L-carnitine, and PDE5 inhibitor
por: Park, Jong Jin, et al.
Publicado: (2016) -
The Outcome of Multiple Slit on Plaque with Plication Technique for the Treatment of Peyronie's Disease
por: Shin, Su Hwan, et al.
Publicado: (2016) -
AB082. The outcome of multiple slit on plaque with plication technique for the treatment of Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016) -
The Prescribing and Dispensing of Phosphodiesterase Type 5 Inhibitors in South Korea: A Questionnaire Survey of Patient Discomfort
por: Kim, Sang Woo, et al.
Publicado: (2014)